Life Sciences

Why Vaccines Should be Part of Your Respiratory Disease Prevention Strategy

Boosting Ontario’s Life Sciences: Insights from an Industry Leader

Durhane Wong-Rieger Discusses Canadian Rare Disease Drug Strategy

Minister Champagne Highlights Canada’s Commitment to Life Sciences Sector Growth

The Value of Real-World Evidence in Canadian Drug Commercialization

Graphic of DNA molecules on a blue background

Toronto Neo Biotech Discovering Patient Solutions with AI

IRICoR header

Quebec Drug Discovery Model Draws Global Attention

IRICoR specializes in drug discovery. Its network and resources are set to benefit a growing pool of Canadian and international drug discovery innovators.

Managing Diabetes

Why We Must Improve Patients’ Access to Innovative Medicines in Canada

Patient Access & Empowerment

Patients Deserve Faster Access to Innovative New Medicines